James Broughel wants to break the link between the willingness-to-pay principle embodied in the value of a statistical life (VSL) and the assessment of mortality-reduction benefits. The use of society’s willingness to pay for benefits, however, is not a concept that is unique to valuing mortality reduction effects. It is the approach used to value all policy benefits. Abandoning the willingness-to-pay measure for benefits would consequently cut across all policy impacts. In Broughel’s view, valuing mortality reduction benefits based on the VSL overvalues these impacts. If basing the valuation of mortality risks on the VSL leads to benefit estimates that are too high, then all market decisions that are used to estimate the VSL are also flaw...